You have 9 free searches left this month | for more free features.

choroidal neovascularization

Showing 1 - 25 of 917

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • +2 more
  • Intravitreal aflibercept injection
  • Seoul, Korea, Republic of
    Jae Hui Kim
Dec 20, 2022

Deep Learning OCT and OCTA in NVC

Recruiting
  • Macular Degeneration Choroidal Neovascularization
  • Diagnostic test: using artificial intelligence to evaluate the changes OCT and OCTA parameter
  • Naples, Italy
    Federico II University
Aug 3, 2023

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • BD311
    • Shanghai, Shanghai, China
      Eye & ENT Hospital of Fudan University
    Aug 22, 2022

    Learn More About How Drug Aflibercept Works in Canadian Reduced

    Active, not recruiting
    • Myopic Choroidal Neovascularization
    • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
    • Multiple Locations, Canada
      Many Locations
    Jul 25, 2022

    Myopic Choroidal Neovascularisation Trial in Guangzhou (3+PRN, 6+PRN)

    Recruiting
    • Myopic Choroidal Neovascularisation
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Feb 8, 2022

    Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,

    Completed
    • Age-Related Macular Degeneration
    • +2 more
    • Early disclosure
    • Late disclosure
    • Salt Lake City, Utah
      University of Utah John A. Moran Eye Center
    Aug 10, 2022

    Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)

    Completed
    • Pathologic Myopia
    • Intravitreal injection
    • Mykolaiv, Ukraine
    • +2 more
    Jan 23, 2023

    Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial

    Recruiting
    • Diabetic Macular Edema
    • +4 more
    • Anti-vascular endothelial growth factors (Anti-VEGFs)
    • Banhā, Benha, Egypt
      Ahmed Abdelshafy Tabl
    Aug 8, 2022

    Choroidal Neovascularization Trial in Sao Paulo (bevacizumab)

    Completed
    • Choroidal Neovascularization
    • Sao Paulo, Brazil
      Hospital das Clínicas- University of Sao Paulo
    Jan 4, 2022

    Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia

    Not yet recruiting
    • Macular Degeneration, Age Related
    • +4 more
    • VISUPRIME
    • Placebo
    • Perugia, PG, Italy
      Ospedale Santa Maria della Misericordia
    Dec 22, 2022

    Macular Degeneration, Choroidal Neovascularization Trial in 'Aiea, Oak Forest (episcleral brachytherapy)

    Recruiting
    • Macular Degeneration, Choroidal Neovascularization
    • episcleral brachytherapy
    • 'Aiea, Hawaii
    • +1 more
    Feb 11, 2022

    OCTA Insights in CNVM, Morphological Characteristics and

    Not yet recruiting
    • Choroidal Neovascularization
      • (no location specified)
      Sep 14, 2021

      Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers, Choroidal Neovascularization Trial in Madrid (SYL18001

      Completed
      • Safety, Tolerability and Pharmacokinetic Profile in Healthy Volunteers
      • Choroidal Neovascularization
      • SYL18001 sodium Low dose q.d
      • +3 more
      • Madrid, Spain
        Sylentis Clinical Trial Site
      Mar 30, 2022

      Real Life Study in Myopic Neovascularization

      Active, not recruiting
      • Myopic Choroidal Neovascularisation
      • AFLIBERCEPT
      • Poitiers, France
        Chu de Poitiers
      Sep 28, 2021

      Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)

      Recruiting
      • Pathological Myopic Choroidal Neovascularization
      • BeiJing, China
        Peking Union Medical College Hospital
      Jun 4, 2021

      Myopic Choroidal Neovascularisation Trial in Beijing (CM082)

      Suspended
      • Myopic Choroidal Neovascularisation
      • Beijing, China
        Peking Union Medical College Hospital
      Mar 7, 2021

      Optical Coherence Tomography Angiography Criteria Of The

      Not yet recruiting
      • Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia
      • Optical coherence tomography angiography
      • (no location specified)
      Sep 27, 2022

      Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)

      Recruiting
      • Pathologic Myopia
      • Intravitreal injection
      • Lutsk, Ukraine
      • +3 more
      Mar 23, 2022

      Anti-VEGF in Real-world

      Recruiting
      • Neovascular Age-related Macular Edema
      • +5 more
      • Beijing, Beijing, China
        Wen-Bin Wei
      Feb 2, 2022

      Choroidal Neovascularization, Wet Macular Degeneration Trial in United States (ICON-1, aflibercept)

      Terminated
      • Choroidal Neovascularization
      • Wet Macular Degeneration
      • ICON-1
      • aflibercept
      • Beverly Hills, California
      • +7 more
      Mar 21, 2021

      Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])

      Completed
      • Central Retinal Vein Occlusion With Macular Edema
      • Ziv-Aflibercept 25 MG/ML [Zaltrap]
      • Tanta, El Gharbia, Egypt
        Tanta University
      Oct 4, 2021

      Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion With Macular Edema Trial in Makati

      Completed
      • Neovascular Age-related Macular Degeneration
      • +4 more
      • Intravitreal injection guide (Malosa)
      • Dual Blade Eyelid Speculum
      • Makati City, MM, Philippines
        Peregrine Eye and Laser Instittute
      Apr 25, 2021

      Neovascular (Wet) Age-related Macular Degeneration Trial (Aflibercept(BAY86-5321, Eylea))

      Not yet recruiting
      • Neovascular (Wet) Age-related Macular Degeneration
      • Aflibercept(BAY86-5321, Eylea)
      • (no location specified)
      Jul 22, 2022

      Chorioretinitis Trial in Mykolaiv, Odessa (Intravitreal injection, Fluorescent angiography, Visometry)

      Unknown status
      • Chorioretinitis
      • Intravitreal injection
      • +6 more
      • Mykolaiv, Ukraine
      • +2 more
      Feb 2, 2021